LSI:FRA
CK Life Sciences Intl (Holdings) Inc
€0.060
arrow_downward
-0.83%(-0.00050) 1D
Nov 13, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LSI...
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
5.14B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.05
No. of employees
2K
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
5.14B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.05
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
Yahoo Finance
·
44 minutes ago
Alibaba (NYSE:BABA) Caught In New US AI Chip Clampdown After Espionage Uproar
TheStreet
·
10 hours ago
Goldman Sachs reset S&P 500 price target for 2027
Foreign Policy Journal
·
34 minutes ago
Vanguard Russell 1000 Value ETF (NASDAQ: VONV) Surges 24.8% In 2026 While Holding Amazon, Apple, And Microsoft Without A Single Nvidia Share
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc
CEOYing Choi Yu
Employees1.92K
Founded2000
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteck-lifesciences.com